Eton Pharmaceuticals (ETON) EV to CFO (2018 - 2025)

Eton Pharmaceuticals has disclosed EV to CFO across 8 years of filings, most recently posting 37.35 for Q4 2025.

• In Q4 2025, EV to CFO rose 91.62% year-over-year to 37.35; the TTM figure through Dec 2025 stood at 40.99 (down 88.35% YoY), while the FY2025 annual figure was 40.99, down 88.35% from the prior year.
• EV to CFO came in at 37.35 for Q4 2025 at Eton Pharmaceuticals, down from 45.37 in the prior quarter.
• In the past five years, EV to CFO ranged from a high of 235.47 in Q4 2023 to a low of 445.53 in Q4 2024.
• Average EV to CFO over 5 years is 6.97, with a median of 19.71 recorded in 2022.
• Year-over-year, EV to CFO slumped 835.29% in 2021 and jumped 1111.66% in 2023.
• Over 5 years, EV to CFO stood at 17.83 in 2021, then surged by 208.99% to 19.43 in 2022, then jumped by 1111.66% to 235.47 in 2023, then tumbled by 289.21% to 445.53 in 2024, then jumped by 91.62% to 37.35 in 2025.
• Per Business Quant data, the three most recent EV to CFO figures were 37.35 in Q4 2025, 45.37 in Q3 2025, and 44.83 in Q2 2025.